Search Antibody, Protein, and ELISA Kit Solutions

BRD9 Antibody - N-terminal region (ARP34803_T100)

100 ul

Regular Price: $249.00

Special Price: $229.00

In Stock
Request Bulk Order Quote

Conjugation Options

ARP34803_T100-FITC Conjugated

ARP34803_T100-HRP Conjugated

ARP34803_T100-Biotin Conjugated

Tested Species Reactivity:
Human, Mouse
Predicted Species Reactivity:
Cow, Dog, Guinea Pig, Horse, Human, Mouse, Rabbit, Rat, Zebrafish
Product Format:
Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
Reconstitution and Storage:
For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles.
Gene Symbol:
Official Gene Full Name:
Bromodomain containing 9
NCBI Gene Id:
Protein Name:
Bromodomain-containing protein 9
Swissprot Id:
Protein Accession #:
Nucleotide Accession #:
Alias Symbols:
PRO9856, LAVS3040
Replacement Item:
This antibody may replace item sc-102170 from Santa Cruz Biotechnology.
Description of Target:
BRD9 is a member of protein family that contains bromodomain. It is potentially related to cancer.
Protein Size (# AA):
Molecular Weight:
Protein A purified
Tissue Tool:
Find tissues and cell lines supported by DNA array analysis to express BRD9.
RNA Seq:
Find tissues and cell lines supported by RNA-seq analysis to express BRD9.
The immunogen is a synthetic peptide directed towards the N terminal region of human BRD9
Predicted Homology Based on Immunogen Sequence:
Cow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 92%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 77%
Complete computational species homology data:
Anti-BRD9 (ARP34803_T100)
Peptide Sequence:
Synthetic peptide located within the following region: VTEFKADFKLMCDNAMTYNRPDTVYYKLAKKILHAGFKMMSKQAALLGNE
Batch dependent within range: 100 ul at 0.5 - 1 mg/ml
Protein Interactions:
Blocking Peptide:
For anti-BRD9 (ARP34803_T100) antibody is Catalog # AAP34803 (Previous Catalog # AAPP06011)
Printable datasheet for anti-BRD9 (ARP34803_T100) antibody
Sample Type Confirmation:

BRD9 is supported by BioGPS gene expression data to be expressed in Jurkat

Target Reference:
Clark,H.F., et al., (2003) Genome Res. 13 (10), 2265-2270

Middeljans, E. et al. SS18 together with animal-specific factors defines human BAF-type SWI/SNF complexes. PLoS One 7, e33834 (2012). WB, Cow, Dog, Guinea Pig, Horse, Human, Mouse, Rabbit, Rat, Zebrafish 22442726

Product Reviews

Average Rating:
1 review
5 star
4 star
3 star
2 star
1 star
  • Date - Newest First
  • Date - Newest First
  • Date - Latest First
  • Highest Rated
  • Lowest Rated
  • Most Helpful
  • Ownership

1 Item(s)

02/01/2017 16:23
  • Overall Experience:
  • Quality:
Product Review: BRD9 antibody-N-terminal region (ARP34803_T100) in mouse melanocytes (melba), mouse melanoma (B16), human melanocytes (HFSC), human melanoma (SK-MEL5), human melanoma (YUMAC) and rat shwann cell using Western blot
Product Page for BRD9 antibody-N-terminal region (ARP34803_T100)

Researcher: Dr. Ivana de la Serna, University of Toledo
Application: Western blotting
Species + Tissue/Cell type: 1: 60ug mouse melanocytes (melba), 2: 60ug mouse melanoma (B16), 3: 60ug human melanocytes (HFSC), 4: 60ug human melanoma (SK-MEL5), 5: 60ug human melanoma (YUMAC), 6: 60ug rat shwann cell

Primary antibody dilution: 1:200
Secondary antibody: Donkey anti-rabbit HPRT
Secondary antibody dilution: 1:2000

How do Aviva's reagents play a role in your experimental goals? We use them for Western blotting
How would you rate this antibody on a scale from 1-5 (5=best) and why? 4.  Westerns showed a predominant band of the right size.
Would you use this antibody in future experiments? Yes
Have you used another antibody which has worked in your application? Yes
Do you believe the information about the reagent on Aviva's website is correct? Yes
If the antibody works, do you plan to use it in future experiments or to publish your data? Why or why not? Yes
How did you store the antibody after re-suspension? At -4 degree C
Sample Description (please include 1) species type, and 2) cell/tissue type, and 3) how much protein loaded for each lane of your gel): Mouse melanocytes (melba), mouse melanoma (B16), human melanocytes (HFSC), human melanoma (SK-MEL5 and YUMAC), rat shwann cell, 60ug
How many different experimental trials were conducted using the antibody sample? Greater than 3
How was this sample prepared? Extraction buffer:
20mM Tris (pH 7.4)
150 mM NaCl
1% Triton X
10% glycerol
Primary antibody dilution and incubation time: 1:200, overnight at 4C and then 1 hour at room temp.
Secondary antibody used and dilution and incubation time: Donkey anti-rabbit HPRT, 1:2000, 1 hour room temp.
What controls were used in your experiment (positive/negative)? None
Please include your detailed WB Procedure/Protocol here: 1. Run 10% SDS-PAGE gel
2. Transfer to PVDF (1 hour )with the following buffer:
57.7g Glycine
12.1g Tris Base
800ml Methanol
bring volume up to 4L with dH2O
3. Block membrane 5% milk/ one hour room temp
4. Wash with 1X PBST
5. Incubate membrane overnight (4C) in antibody made in 2% BSA/PBST
6. Incubate membrane at room temp 1 hour in antibody
7. Wash 3X (15min each) with PBST at room temp
8. Incubate with rabbit secondary (1;2000)/ 2% milk/PBST, one hour room temp
9. Wash 3X (15min each) with PBST at room temp
10. Develop with ECL (Supersignal, Dura, Pierce)
Show more comments (-2) Hide comments

1 Item(s)

What kind of abuse are you reporting?
    Please, wait...